Featured Industry Spotlight

Protected: New first-in-class treatment for chronic graft-versus-host disease following stem-cell transplant

By ONA Editor November 25, 2021 No Comments

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

This post is password protected. Enter the password to view comments.

About Author

Related Posts

Researchers identify strategy for reducing risk of acute graft-versus-host disease for many with blood cancers

New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications

ASH 2024: A fibre-rich diet may help prevent complications after stem cell transplant